Effects of phosphodiesterase 3A modulation on murine cerebral microhemorrhages

Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion

(2016) Hamidreza Edrissi et al.   BRAIN RESEARCH

A murine model of inflammation-induced cerebral microbleeds

(2016) Rachita K. Sumbria et al.   Journal of Neuroinflammation

Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study

(2015) A. Shoamanesh et al.   NEUROLOGY

Comparative Analysis of H&E and Prussian Blue Staining in a Mouse Model of Cerebral Microbleeds

(2014) Shuo Liu et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Advances in targeting cyclic nucleotide phosphodiesterases

(2014) Donald H. Maurice et al.   NATURE REVIEWS DRUG DISCOVERY

Cerebral Microbleeds

(2014) Zhaolu Wang et al.   STROKE

Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid

(2014) Takakuni Maki et al.   Annals of Clinical and Translational Neurology

Select 3′,5′-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain

(2013) Michy P. Kelly et al.   CELLULAR SIGNALLING

Cilostazol Ameliorates Warfarin-Induced Hemorrhagic Transformation After Cerebral Ischemia in Mice

(2013) Akira Kitashoji et al.   STROKE

Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties

(2012) Shuo Liu et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Mixed Cerebrovascular Disease and the Future of Stroke Prevention

(2012) Mark Fisher et al.   Translational Stroke Research

Anti-platelet therapy: phosphodiesterase inhibitors

(2011) Paolo Gresele et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia

(2011) Yoshiki Hase et al.   EXPERIMENTAL NEUROLOGY

Therapeutic Modulation of Cerebral Microhemorrhage in a Mouse Model of Cerebral Amyloid Angiopathy

(2011) Mark Fisher et al.   STROKE

Cilostazol Reduces the Risk of Hemorrhagic Infarction After Administration of Tissue-Type Plasminogen Activator in a Murine Stroke Model

(2011) Yukiko Kasahara et al.   STROKE

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

(2010) Yukito Shinohara et al.   LANCET NEUROLOGY

Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy

(2010) A. Biffi et al.   NEUROLOGY

Phosphodiesterase-III Inhibitor Prevents Hemorrhagic Transformation Induced by Focal Cerebral Ischemia in Mice Treated with tPA

(2010) Mitsunori Ishiguro et al.   PLoS One

Protein Kinase C-mediated Phosphorylation and Activation of PDE3A Regulate cAMP Levels in Human Platelets

(2009) Roger W. Hunter et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca2+responses in endothelial cells

(2008) M Campos-Toimil et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study

(2008) Yining Huang et al.   LANCET NEUROLOGY